CorMedix Inc. (CRMD) Risk Assessment & Volatility Analysis

Comprehensive risk assessment and volatility analysis for CRMD including beta analysis, market risk, financial risk, and investment risk evaluation. Understand the potential risks and rewards of investing in CRMD stock with expert risk management insights.

Risk Assessment Summary

High market volatility (Beta > 1.5)

High price volatility

Low governance risk

Governance Risk

Overall Risk Score

4/100Low

Audit Risk

6/100Low

Board Risk

5/100Low

Compensation Risk

8/100Low

Shareholder Rights Risk

1/100Low

Market Risk

Beta (5Y Monthly)

1.71High

52-Week Change

153.94%Very High

S&P 500 52-Week Change

16.84%Very High

Short Interest Ratio

4.77Very High

Short % of Float

19.19%Very High

Volatility (Annualized)

88.45%Very High

Financial Risk

Total Debt

$435.25K

Enterprise Value

$916.77M

Profit Margins

42.11%Low

Earnings Growth (QoQ)

N/A

Net Income to Common

$51.16M

Book Value

$2.96

Risk vs Reward Analysis

Risk Factors

Beta: 1.71

Volatility: 88.45%

Short Interest: 4.77

Potential Rewards

52-Week Change: 153.94%

Earnings Growth: N/A

Profit Margin: 42.11%